Posts Tagged ‘PCA3 test’

NEW PROSTATE CANCER INFOLINK:  A new way to test negative biopsy samples to see if in fact prostate cancer is present will be tested on 500 US volunteers. READ MORE>

Gen-Probe announced yesterday that it has begun a clinical trial designed to seek U.S. regulatory approval of the PROGENSA® PCA3 assay. Gen-Probe to market their PCA3 test only for the evaluation of prostate cancer risk in patients who had had at least one negative biopsy.

Read Full Post »

MAY 16: NEW PROSTATE CANCER INFO-LINK:  The results of at least 15 prostate cancer-related studies will be presented at the upcoming annual meeting of the American Society for Clinical Oncology in Orlando, Florida, at the end of May. READ MORE>

Read Full Post »